This website uses cookies. By using our website you consent to all cookies in accordance with our Privacy Policy. Read more - OK, thanks

Back to Board


Professor Susanna Esposito is Director of the Pediatric Clinic, Department of Surgical and Biomedical Sciences, at the Università degli Studi di Perugia (Italy).

Former Director of the Pediatric Highly Intensive Care Unit at the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico in Milan, Italy, she was also Chief of the outpatient clinic for travel medicine and head of the Lompardy Region’s Lyme Disease Centre. Prof. Esposito was also Chief of one of the paediatric HIV clinics in the Regione Lombardia, coordinator of the Epidermolysis Bullosa Centre and an Associate Professor in Pediatrics at the Department of Maternal and Pediatric Sciences, Università degli Studi di Milano, Milan, Italy.

In July 2014, Susanna Esposito founded WAidid and she is the President.

From 2011 to 2014 she was President of the Italian Society of Pediatric Infectious Diseases (SITIP); she is also a member of the Steering committee on vaccines of the Italian Society of Allergy and Immunology, President of the WHO Committee for measles and rubella eradication and Chair of the Vaccines Group of the European Society for Clinical Microbiology and Infectious Diseases (EVASG).

She has been a member of the Steering Committee of the European Society of Paediatric Infectious Diseases (ESPID) (2004-2007) and a member of the Committees for Training and Research of ESPID (2007-2013).

She won several postgraduate awards; she has been International Editor of The Paediatric Infectious Disease Journal (since 2005), Associate Editor of BMC Infectious Diseases (since 2009), Associate Editor of Human Vaccines (since 2010), Associate Editor of Journal of Clinical Virology and Editorial Board Member of PLOS One (since 2013). Prof. Esposito’s research has focused on respiratory tract infections, vaccines and preventive paediatrics, antibiotic therapy and emerging infections. Her research activities has led to the publication of more than 200 articles in international journals reported by PubMed with an h index of 36 and an impact factor >1,000.